Dr. Scott E. Delacroix
Claim this profileLSU Healthcare Network / Metairie Multi-Specialty Clinic
Expert in Prostate Cancer
Expert in Cancer
26 reported clinical trials
61 drugs studied
About Scott E. Delacroix
Education:
- Received MD (Doctor of Medicine) from Louisiana State University School of Medicine, New Orleans, in 1987.
Experience:
- Board Certified in Internal Medicine by the American Board of Internal Medicine.
- Currently practicing at LSU Healthcare Network / Metairie Multi-Specialty Clinic.
Area of expertise
1Prostate Cancer
Global LeaderStage IV
synaptophysin positive
chromogranin positive
2Cancer
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Scott E. Delacroix is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
More about Scott E. Delacroix
Clinical Trial Related2 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 15 Active Clinical TrialsTreatments Scott E. Delacroix has experience with
- Gemcitabine Hydrochloride
- Radiation Therapy
- Bicalutamide
- Flutamide
- Atezolizumab
- Prednisone
Breakdown of trials Scott E. Delacroix has run
Prostate Cancer
Cancer
Bladder Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Scott E. Delacroix specialize in?
Scott E. Delacroix focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Scott E. Delacroix currently recruiting for clinical trials?
Yes, Scott E. Delacroix is currently recruiting for 14 clinical trials in Metairie Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Scott E. Delacroix has studied deeply?
Yes, Scott E. Delacroix has studied treatments such as Gemcitabine Hydrochloride, Radiation Therapy, Bicalutamide.
What is the best way to schedule an appointment with Scott E. Delacroix?
Apply for one of the trials that Scott E. Delacroix is conducting.
What is the office address of Scott E. Delacroix?
The office of Scott E. Delacroix is located at: LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana 70006 United States. This is the address for their practice at the LSU Healthcare Network / Metairie Multi-Specialty Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.